Case Report
Published on 06 Oct 2022
Case report: Immune-mediated meibomian gland dysfunction following pembrolizumab therapy for advanced urothelial carcinoma
in Genitourinary Oncology
- 2,525 views
- 1 citation
Case Report
Published on 06 Oct 2022
in Genitourinary Oncology
Original Research
Published on 04 Oct 2022
in Genitourinary Oncology
Review
Published on 04 Oct 2022
in Genitourinary Oncology
Editorial
Published on 04 Oct 2022
in Genitourinary Oncology
Original Research
Published on 03 Oct 2022
in Genitourinary Oncology
Case Report
Published on 03 Oct 2022
in Genitourinary Oncology
Case Report
Published on 29 Sep 2022
in Genitourinary Oncology
Opinion
Published on 29 Sep 2022
in Genitourinary Oncology
Systematic Review
Published on 29 Sep 2022
in Genitourinary Oncology
Original Research
Published on 29 Sep 2022
in Genitourinary Oncology
Review
Published on 29 Sep 2022
in Genitourinary Oncology
Review
Published on 29 Sep 2022
in Genitourinary Oncology
Original Research
Published on 28 Sep 2022
in Genitourinary Oncology
Original Research
Published on 28 Sep 2022
in Genitourinary Oncology
Original Research
Published on 28 Sep 2022
in Genitourinary Oncology
Editorial
Published on 28 Sep 2022
in Genitourinary Oncology